|
TATDN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63502544836547E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.83149109398573E-12 |
| Normal-vs-Stage2 |
6.69359999649899E-08 |
| Normal-vs-Stage3 |
1.99682999999506E-05 |
| Normal-vs-Stage4 |
2.180800E-04 |
| Stage1-vs-Stage2 |
9.049000E-01 |
| Stage1-vs-Stage3 |
4.419200E-01 |
| Stage1-vs-Stage4 |
5.770000E-01 |
| Stage2-vs-Stage3 |
5.856200E-01 |
| Stage2-vs-Stage4 |
5.562800E-01 |
| Stage3-vs-Stage4 |
9.785800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63880020664919E-12 |
| Normal-vs-AfricanAmerican |
2.06169999961148E-08 |
| Normal-vs-Asian |
1.433530E-04 |
| Caucasian-vs-AfricanAmerican |
4.333400E-01 |
| Caucasian-vs-Asian |
4.216600E-01 |
| AfricanAmerican-vs-Asian |
3.533200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63502544836547E-12 |
| Normal-vs-Female |
8.65139959671524E-10 |
| Male-vs-Female |
5.210200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.00489999987907E-07 |
| Normal-vs-Extreme_Weight |
1.67821312402339E-12 |
| Normal-vs-Obese |
1.91170002050711E-09 |
| Normal-vs-Extreme_Obese |
3.064200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.166800E-01 |
| Normal_Weight-vs-Obese |
5.225600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.213600E-01 |
| Extreme_Weight-vs-Obese |
6.331200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.770400E-01 |
| Obese-vs-Extreme_Obese |
4.737200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.38720000000914E-06 |
| Normal-vs-Age(41-60Yrs) |
3.47544215628659E-12 |
| Normal-vs-Age(61-80Yrs) |
1.84585680074179E-12 |
| Normal-vs-Age(81-100Yrs) |
1.83369999962046E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.458600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.952800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.881760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.167400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.429700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.054200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
5.43630000016115E-07 |
| Normal-VS-KIRP CIMP |
7.83920000024807E-07 |
| Normal-VS-Unclassified PRCC |
2.09859996047612E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.761000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.288020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.963000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.958380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.267000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.130600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.95392615817991E-12 |
| Normal-vs-N1 |
6.35260000048099E-07 |
| Normal-vs-N2 |
4.200200E-04 |
| N0-vs-N1 |
4.519600E-01 |
| N0-vs-N2 |
4.513200E-01 |
| N1-vs-N2 |
3.450200E-01 |
|
|
